Physician profile
Donald Cinotti
NPI 1255449153
$1,056.72
in general payments reported to CMS, 2019-2025
11 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.26 · 2020: $5.68 · 2021: $34.99 · 2022: $58.31 · 2023: $108 · 2024: $421 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $249.54 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $153.48 | 2024 | Envista Mx60 Iol, Doctors Allergy Formula, Vyzulta |
| Sun Pharmaceutical Industries INC. | $134.90 | 2019-2024 | |
| Biotissue Holdings INC. | $126.29 | 2019-2025 | |
| Glaukos Corporation | $111.10 | 2025 | Idosetr |
| Dompe US, INC. | $107.63 | 2023 | Oxervate |
| Oyster Point Pharma, INC. | $66.23 | 2022-2025 | Tyrvaya, Ryzumvi |
| Horizon Therapeutics Plc | $43.58 | 2022 | |
| Alcon Vision LLC | $37.45 | 2021-2025 | Rocklatan |
| Mallinckrodt Hospital Products INC. | $15.00 | 2021 | |
| Allergan, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Cinotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.